Publications & Works

Publication Network
Journal articles indexed in SCI, SSCI, and AHCI

Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients

Yiğit Kaya S., MUTLU Y. G., YÜCEL O. K., Nizam Özen İ., Ataş Ü., MELEK E., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , 2024 (SCI-Expanded) identifier identifier

Germline CEBPA Mutation as a Rare Cause of Chronic Neutropenia

Askin A. E., Bektas S., Serin I., MUTLU Y. G., Aydin B. B., SEVİNDİK Ö. G.
Indian Journal of Hematology and Blood Transfusion , vol.40, no.3, pp.527-530, 2024 (SCI-Expanded) identifier

Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience

Yiğit Kaya S., MUTLU Y. G., MALKAN Ü. Y., MEHTAP Ö., Keklik Karadağ F., Korkmaz G., et al.
LEUKEMIA RESEARCH , vol.140, 2024 (SCI-Expanded) identifier identifier identifier

Predicting the CD34 content of mobilized peripheral blood leukapheresis products: single institution experience over 20 years

MUTLU Y. G., Sevcik J., Kiss J. E., Lister J., Moore L. R., Donnenberg A. D.
Cytotherapy , vol.26, no.2, pp.171-177, 2024 (SCI-Expanded) identifier identifier

Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?

Serin I., SEVİNDİK Ö. G., Balik Aydin B., MELEK E., MUTLU Y. G., BİLGEN H., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.62, no.6, 2023 (SCI-Expanded) identifier identifier identifier

Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case

Mutlu Y. G., Yıgıt Kaya S., Maral S., Melek E., Başlar Z., Kaynar L., et al.
FRONTIERS IN IMMUNOLOGY , vol.14, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier

Intravascular B-cell lymphoma with generalized telangiectasias

Erol V. B., MUTLU Y. G., Balik B., MERT A., Mergen S., Mergen M., et al.
JDDG - Journal of the German Society of Dermatology , vol.21, no.9, pp.1025-1027, 2023 (SCI-Expanded) identifier identifier

Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient

Yiğit Kaya S., Bektas S., Askin A. E., Balık Aydın B., MUTLU Y. G., SEVİNDİK Ö. G.
Annals of Hematology , vol.102, no.6, pp.1599-1600, 2023 (SCI-Expanded) identifier identifier identifier

Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation: Intensive Care Outcome in Hematopoietic Stem Cell Transplantation

MUTLU Y. G., Aydin B. B., ERDOĞAN C., KIZILASLAN D., BEKÖZ H. S., Gemici A., et al.
Indian Journal of Hematology and Blood Transfusion , vol.39, no.2, pp.167-172, 2023 (SCI-Expanded) identifier identifier identifier

To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission

SEVİNDİK Ö. G., Mergen M., Mergen S., MUTLU Y. G., Aydın B. B., Serin I.
Annals of Hematology , vol.101, no.11, pp.2545-2547, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

Persistent polyclonal b-cell lymphocytosis with binucleated lymphocytes Çift çekirdekli lenfositler ile karakterize, kalıcı poliklonal b-hücreli lenfositoz

Aydın B. B., MUTLU Y. G., SEVİNDİK Ö. G.
Turkish Journal of Hematology , vol.38, no.2, pp.173-174, 2021 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier
Articles Published in Other Journals

Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers

Sadri S., Yonal-Hindilerden I., mutlu Y. g., tiryaki t. o., Gemici A., Beköz H. S., et al.
The European Research Journal , vol.9, no.6, pp.1368-1379, 2023 (Peer-Reviewed Journal) Creative Commons License identifier

Should Core Needle Lymph Node Biopsy be a Relevant Alternative to Surgical Excisional Biopsy in Diagnostic Work Up of Lymphomas?

MUTLU Y. G., BALIK B., CAKİR A., CANÖZ Ö., EROL C., SEVİNDİK Ö.
Eurasian Journal of Medicine , vol.55, no.2, pp.114-119, 2023 (ESCI) identifier identifier identifier

First-line Usage of Daratumumab, Lenalidomide, Dexamethasone (DRd) Combination in a Case of Castleman Disease Variant of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome (CD-POEMS)

SEVİNDİK Ö. G., MUTLU Y. G., Aydin B. B., Serin I.
HemaSphere , vol.6, no.7, 2022 (Scopus) identifier identifier identifier

Mutation profile of the patients diagnosed with myeloid neoplasia tested with next generation sequencing and clinical implications

MUTLU Y. G., BALIK B., AYAZ A., SECA F., SEVİNDİK Ö.
Annals of Medical Research , vol.29, no.4, pp.406-411, 2022 (Peer-Reviewed Journal) identifier
Papers Presented at Peer-Reviewed Scientific Conferences

SANTRAL SİNİR SİSTEMİ TUTULUMU (SSS) İLE SEYREDEN BİR MULTİPL MYELOM HASTASINDA ELRANATAMAB İLE ELDE EDİLEN YÜZ GÜLDÜRÜCÜ YANIT

MUTLU Y. G., YİĞİT KAYA S., MARAL S., MELEK E., BAŞLAR Z., KAYNAR L., et al.
49.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 05 November 2023, (Full Text)

MULTIPLE MYELOM HASTALARININ MOBILIZASYONUNDA JENERİK PLERİXAFOR İLE ORİJİNAL PLERİXAFORUN ETKİNLİK VE GÜVENLİĞİNİN KARŞILAŞTIRILMASI: ÇOK MERKEZLİ ÇALIŞMA

YİĞİT KAYA S., MUTLU Y. G., YÜCEL O. K., ÖZEN İ. N., ATAŞ Ü., MELEK E., et al.
49. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 05 November 2023, (Full Text)

YÜKSEK DOZ METOTREKSATIN BAŞARISIZ OLDUĞU SEKONDER SSS LENFOMA OLGUSUNDA TEDDI-R İLE TRANSPLANTASYONA BAŞARILI BİR KÖPRÜ TEDAVİ

YİĞİT KAYA S., MELEK E., MUTLU Y. G., BEKÖZ H. S., MARAL S., KAYNAR L., et al.
49.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 05 November 2023, (Full Text)

PLERIXAFOR IN AUTOLOGOUS STEM CELL TRANSPLANTATION: DOES IT AFFECT ENGRAFTMENT KINETICS?

SERİN İ., SEVİNDİK Ö. G., BALIK AYDIN B., MELEK E., MUTLU Y. G., BİLGEN H., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Paris, France, 23 - 26 April 2023, pp.378-379, (Summary Text)

IBCL-386: Rituximab-Vemurafenib Combination for the Treatment of Relapsed/Refractory Hairy Cell Leukemia

SEVİNDİK Ö. G., GEMİCİ A., MUTLU Y. G., BALIK AYDIN B., ÇAKIR A.
Society of Hematologic Oncology Eighth Annual Meeting, Houston, United States Of America, 9 - 12 September 2020, (Full Text)
Books

Chapter 23: Extracorporeal Photopheresis in Patients with Chronic Graft-Versus-Host Disease

KAYNAR L., MUTLU Y. G.
in: Problem Solving in Apheresis Medicine, İlknur KOZANOĞLU, Editor, Springer Nature Switzerland AG, pp.1-14, 2023